Navigation Links
External CounterPulsation (ECP) Centers

ProductsExternal CounterPulsation (ECP) Centers
Company MedCath Corporation
Item External CounterPulsation (ECP) Centers
Features ECP Clinical Benefits

Clinical studies have shown that ECP treatment produces improved perfusion of the ischemic myocardium in patients with coronary artery disease. The following patient benefits have been observed:

  • Relief of anginal symptoms
  • Resolution of reversible ischemic defects found upon radio nuclide assessment
  • Improved exercise treadmill times
  • Rectification of exercise ECG ST segment abnormalities
  • No need or reduction of need for anti-anginal medication
  • Improved ability to perform normal activities of daily living
The ACC and Mayo Clinic recently recommended ECP for certain angina patients.
Description Looking for a way to help your patients with chronic angina or end stage cardiovascular disease? Based on the outcomes of several thousand cardiac patients nationwide, External Counterpulsation (ECP) has improved the quality of their lives; it has allowed many to perform normal activities of daily living.

MedCath Diagnostics, LLC, a national provider of cardiac diagnostic services, has assisted physicians with placing this proven cardiac treatment therapy within their office and/or diagnostic centers. We will help with the upfront investment needed to purchase equipment and our development staff will establish a turnkey facility that leaves you free to care for your patients.

Description of Therapy

Patients lie on a bed wearing a series of compressive air cuffs (resembling Blood Pressure cuffs) that are wrapped around the patients legs. The vascular networks in the large muscles of patients legs are compressed in sequence, progressing from the calves upward. Each wave of pressure is electronically synchronized with the patients heartbeat via a microprocessor-interpreted ECG signal, so that the increased blood flow is delivered to the heart at the precise moment of diastole. The result is much higher coronary flow and perfusion as well as increased venous return. Recent studies suggest that ECP promulgates the development of new collaterals to ischemic regions of the myocardium through angiogenesis.

Treatment Course

The recommended regimen is once daily, one-hour treatment, five (5) days a week for seven (7) weeks. Twice daily treatments are an option for some patients, to reduce treatment course duration.

Medicare covers ECP and the reimbursement rates have steadily risen over the past several years. Reimbursement rates for 2003 increased eleven (11) percent from 2000 rates. ECP centers across the country report reimbursement successes with nearly all third party reimbursement payors.

Info MedCath Corporation
Customer Service: (704) 708-6600
Web site: http://www.medcath.com

Related medicine products :

1. The External Neurological Drainage System
2. Monitorr ICP External CSF Drainage and Monitoring System
3. Monitorr ICP External CSF Drainage System
4. EDS 3 CSF External Drainage System
5. Lumbar External Drainage System (LED)
6. External Ventricular Drainage (EVD)
7. Becker External Drainage and Monitoring System
8. Dual-Chamber Model 5388 External (Temporary) Pulse Generator
9. Single-Chamber Model 5348 External (Temporary) Pulse Generator
10. The Hoffmann® II For External Fixation
11. XCaliber External Fixator
Inquire...
Inquire...
... Optimal for Subcellular Fractionation, ... x g (30,000 rpm) with ... from 0.25 up to 85 ... 2° C to 40° C ...
... Fractionation, Proteins and Viruses • ... with fixed-angle rotor • Spin ... 85 mL • Operating temperature ... C • Rotors certified by ...
Medicine Products:
(Date:8/20/2014)... GA (PRWEB) August 20, 2014 ... to healthcare, Jvion successfully predicted stage iii and ... that, in some situations, approached 90%. A company ... been achieved in commercial or academic settings. The ... prevent all types of hospital-acquired conditions to help ...
(Date:8/20/2014)... Oshkosh, Wisconsin (PRWEB) August 20, 2014 ... to the general public at fair prices. The well-known ... ability, and she is now touring in 19 cities, ... locations where the television personality will visit are Albany, ... Kalamazoo, Colorado Springs, Albuquerque, Beverly Hills and San Diego. ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Blaine ... the innovative RevitaDERM® Psoriasis Treatment to ... associated with psoriasis. This all-in-one product was created ... RevitaDERM® Psoriasis Treatment is powered by coal tar ... associated with this effective ingredient. , RevitaDERM® ...
(Date:8/20/2014)... August 20, 2014 The “Human ... Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid ... Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to ... drivers,restraints, challenges, opportunities, current market trends,and strategies impacting ... estimates and forecasts of the revenue and share ...
(Date:8/20/2014)... 20, 2014 AttorneyOne.com, a recognized authority on ... from the FDA on Sodium Chloride IV . ... lot of Sodium Chloride IV 0.9%, USP 1000 mL, by ... presence of particulate matter. Sodium Chloride Injection, USP is used ... priming solution in hemodialysis procedures. , The reason ...
Breaking Medicine News(10 mins):Health News:Jvion Achieves Benchmark Accuracy in Pressure Ulcer Prediction 2Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2Health News:RevitaDERM® Psoriasis Treatment Now Available At Over 7,600 CVS/pharmacies 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Sodium Chloride IV 0.9% by Baxter Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2
... Steven Reinberg HealthDay Reporter , WEDNESDAY, Aug. 3 ... detect prostate cancer and better evaluate a patient,s treatment options, ... their physician can use to help them decide whether it,s ... said lead researcher Dr. Scott Tomlins, a pathology resident at ...
... , WEDNESDAY, Aug. 3 (HealthDay News) -- Many Americans believe ... is, a new survey finds. The telephone poll of ... be like a video camera that records detailed information for ... the participants believed that once experiences are stored as memory, ...
... , Arriving at a rapid and accurate diagnosis is critical ... officials have had to choose between a highly accurate yet ... new detection method developed at the University of Georgia and ... however, offers the best of both worlds. By coating ...
... Mayo Clinic orthopedic surgeon suspects that the nagging pain ... may be different from what men encounter, and she ... to explore the question. The Society for Women,s Health ... Network on Musculoskeletal Health has awarded a group of ...
... News) -- Vampire bats have heat-detecting molecules that help guide ... long been known that vampire bats know where to bite ... a vein, but the researchers believe this is the first ... Venezuelan researchers investigated wild vampire bats in South America and ...
... ranging from artificial hip joints to dentures and catheters, become ... called biofilms that are resistant to the human immune system ... However, researchers may have a new way of looking ... Iowa biologist David Soll and his colleagues published in the ...
Cached Medicine News:Health News:Urine Test Might Help Predict Prostate Cancer Risk 2Health News:Urine Test Might Help Predict Prostate Cancer Risk 3Health News:Memories Can Be Unreliable, Manipulated 2Health News:UGA researchers use gold nanoparticles to diagnose flu in minutes 2Health News:UGA researchers use gold nanoparticles to diagnose flu in minutes 3Health News:Mayo Clinic examines why knee osteoarthritis afflicts more women than men 2
(Date:8/19/2014)... KIRKLAND, Wash. , Aug. 19, 2014 ... solutions, will be exhibiting at the 2014 NPPA Summer ... The company will be showcasing its 340B software products ... leader in 340B splitting solutions, supplying over 400 customers ... a range of 340B solutions including its latest solution, ...
(Date:8/19/2014)... YORK , Aug. 19, 2014 /PRNewswire-iReach/ -- ChemImage ... will present a scientific poster describing an innovative diagnostic ... SPEC 2014: Shedding New Light on Disease (SPEC) conference ... Dr. Treado,s poster entitled, "Development of in vitro ... Imaging" will be discussed during the conference poster session ...
(Date:8/19/2014)... , Aug. 19, 2014  Tokyo-based Atonarp Inc. ... funding round led by Walden Riverwood Ventures with ... development of Atonarp,s Smart Spectrometer technology platform, which ... company has targeted the oil & gas and ... "We are excited to partner with Atonarp in ...
Breaking Medicine Technology:Talyst Exhibits at the NPPA Summer Conference 2ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2